-
PRAC highlights June 2021
PRAC highlights June 2021
-
PRAC highlights June 2021
PRAC highlights June 2021
Outcomes from the June meeting cover all aspects of the risk management of the use of medicines, including COVID-19 vaccines
-
Additional manufacturing sites for Moderna vaccine
Additional manufacturing sites for Moderna vaccine
-
Additional manufacturing sites for Moderna vaccine
Additional manufacturing sites for Moderna vaccine
EMA’s human medicines committee (CHMP) has approved additional manufacturing capacity for Moderna COVID-19 vaccine
-
Janssen vaccine: steps to safeguard quality
Janssen vaccine: steps to safeguard quality
-
Janssen vaccine: steps to safeguard quality
Janssen vaccine: steps to safeguard quality
Authorities in the EU take steps to safeguard the quality of the COVID-19 Vaccine Janssen following contamination with materials for another vaccine manufactured at the same site
-
ICMRA-WHO joint statement published today
ICMRA-WHO joint statement published today
-
ICMRA-WHO joint statement published today
ICMRA-WHO joint statement published today
Global regulators and WHO have developed a statement to help healthcare professionals increase trust and confidence in COVID-19 vaccines among patients and answer their questions
